Skip to main content
Log in

Increased CVD risk even with low oral glucocorticoid doses

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Pujades-Rodriguez M, et al. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLOS One : 3 Dec 2020. Available from: URL: https://doi.org/10.1371/journal.pmed.1003432

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Increased CVD risk even with low oral glucocorticoid doses. Reactions Weekly 1835, 6 (2020). https://doi.org/10.1007/s40278-020-87450-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-87450-0

Navigation